CRISPR Therapeutics (CRSP) shares outstanding

Shares outstanding · fiscal 2025
89.93M

CRISPR Therapeutics (CRSP) had 89.93M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 6.6% higher than the 84.36M of fiscal 2024. Figures as of 18 Nov 2026, 12:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
89.93M
Change on fiscal 2024
+6.6%
Growth, 5 years
+6.4% a year
Highest on record
89.93Mfiscal 2025
Lowest on record
40.06Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

CRISPR Therapeutics shares outstanding, in more detail

The market data feed counts 97.00M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 6.4% a year. Across the 9 fiscal years on record (2017–2025), the highest was 89.93M in fiscal 2025 and the lowest 40.06M in fiscal 2017.

History · 9 fiscal years

Shares outstanding by fiscal year

CRISPR Therapeutics shares outstanding, year by year

CRISPR Therapeutics (CRSP) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202589.93M 6.6% up
202484.36M 6.5% up
202379.22M 1.9% up
202277.75M 3.3% down
202180.39M 21.9% up
202065.95M 15.8% up
201956.93M 18.7% up
201847.96M 19.7% up
201740.06M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on CRSP

CRISPR Therapeutics, figure by figure

CRISPR Therapeutics (CRSP) overview: price, valuation and scorecardAll health care companies by market value

CRISPR Therapeutics shares outstanding: questions and answers

How many shares does CRISPR Therapeutics have?

CRISPR Therapeutics (CRSP) had 89.93M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 6.6% higher than the 84.36M of fiscal 2024. The market data feed counts 97.00M shares outstanding today.

What is the growth rate of CRISPR Therapeutics's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 6.4% a year.

What are the highest and lowest diluted share count figures on record for CRISPR Therapeutics?

Across the 9 fiscal years on record (2017–2025), the highest was 89.93M in fiscal 2025 and the lowest 40.06M in fiscal 2017.

How is CRISPR Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For CRISPR Therapeutics it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CRISPR Therapeutics (CRSP) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/CRSP/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.